The AVISÉ program provides non-repayable financial support to innovative Quebec-based life sciences companies for the real-world evaluation of new or significantly improved health technologies close to commercialization.
The AVISÉ program provides non-repayable financial support to innovative Quebec-based life sciences companies for the real-world evaluation of new or significantly improved health technologies close to commercialization. It funds a real-world use study to demonstrate the overall value of an innovation to future customers, including its economic, population, clinical, organizational, sociocultural, and environmental impact. These projects are carried out in collaboration with the expert evaluation teams of the Health Evaluation and Innovation Network (RÉIS).
Other programs in the same space.
1871
Natural Resources Canada (NRCan)
500 Global
500 Global
